Tacrolimus and Intussusception - a phase IV clinical study of FDA data

Summary:

Intussusception is reported as a side effect among people who take Tacrolimus (tacrolimus), especially for people who are male, 2-9 old, have been taking the drug for 6 - 12 months also take Sirolimus, and have Immunodeficiency disorders.

The phase IV clinical study analyzes which people have Intussusception when taking Tacrolimus. It is created by eHealthMe based on reports of 115,828 people who have side effects when taking Tacrolimus from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Intussusception?

Intussusception is found to be associated with 121 drugs and 262 conditions by eHealthMe. Check the latest studies of Intussusception.

On Aug, 03, 2026

115,828 people reported to have side effects when taking Tacrolimus.
Among them, 27 people (0.02%) have Intussusception.

Among these 27 people:

How long have people been on Tacrolimus when they have Intussusception? *

What is the gender of people who have Intussusception when taking Tacrolimus? *

female: 46.15 %
male: 53.85 %

What is the age of people who have Intussusception when taking Tacrolimus? *

What are other drugs people take besides Tacrolimus? *

What are other side effects people have besides Intussusception? *

Post Transplant Lymphoproliferative Disorder: 11 people, 40.74%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 29.63%
Abdominal Pain: 7 people, 25.93%
Smooth Muscle Cell Neoplasm (tumour of smooth muscle): 5 people, 18.52%
Pneumatosis Intestinalis (air or gas in an intestine): 5 people, 18.52%
Intestinal Obstruction: 5 people, 18.52%
Nausea And Vomiting: 4 people, 14.81%
Drug Ineffective: 4 people, 14.81%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 14.81%
Intestinal Ischaemia (decreased supply of oxygenated blood to the intestines): 3 people, 11.11%

What are the existing conditions these people have? *

Immunodeficiency Disorders: 3 people, 11.11%
Epstein-Barr Virus Infection: 1 person, 3.70%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and have Intussusception?

- Check whether Intussusception is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tacrolimus:

Tacrolimus (116,160 reports)

Intussusception treatments and more:

Intussusception (1,063 reports)

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intussusception:

Intussusception (121 drugs)

Browse all the conditions that are associated with Intussusception:

Intussusception (262 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Tacrolimus) and Tacrolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.